These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16611012)

  • 1. Inhibition of GSK3 dependent tau phosphorylation by metals.
    Gómez-Ramos A; Domínguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J
    Curr Alzheimer Res; 2006 Apr; 3(2):123-7. PubMed ID: 16611012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation.
    Gómez-Ramos A; Domínguez J; Zafra D; Corominola H; Gomis R; Guinovart JJ; Avila J
    J Neurosci Res; 2006 Feb; 83(2):264-73. PubMed ID: 16397900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3 and tau: two convergence points in Alzheimer's disease.
    Hernandez F; Lucas JJ; Avila J
    J Alzheimers Dis; 2013; 33 Suppl 1():S141-4. PubMed ID: 22710914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
    Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
    J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
    Georgievska B; Sandin J; Doherty J; Mörtberg A; Neelissen J; Andersson A; Gruber S; Nilsson Y; Schött P; Arvidsson PI; Hellberg S; Osswald G; Berg S; Fälting J; Bhat RV
    J Neurochem; 2013 May; 125(3):446-56. PubMed ID: 23410232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3: a drug target for CNS therapies.
    Bhat RV; Budd Haeberlein SL; Avila J
    J Neurochem; 2004 Jun; 89(6):1313-7. PubMed ID: 15189333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3.
    Feyt C; Kienlen-Campard P; Leroy K; N'Kuli F; Courtoy PJ; Brion JP; Octave JN
    J Biol Chem; 2005 Sep; 280(39):33220-7. PubMed ID: 16014628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement.
    Baum L; Seger R; Woodgett JR; Kawabata S; Maruyama K; Koyama M; Silver J; Saitoh T
    Brain Res Mol Brain Res; 1995 Dec; 34(1):1-17. PubMed ID: 8750856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
    Noble W; Planel E; Zehr C; Olm V; Meyerson J; Suleman F; Gaynor K; Wang L; LaFrancois J; Feinstein B; Burns M; Krishnamurthy P; Wen Y; Bhat R; Lewis J; Dickson D; Duff K
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6990-5. PubMed ID: 15867159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ.
    Cho JH; Johnson GV
    J Biol Chem; 2004 Dec; 279(52):54716-23. PubMed ID: 15494420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
    Avila J; Wandosell F; Hernández F
    Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK3: a possible link between beta amyloid peptide and tau protein.
    Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
    Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation.
    Stoothoff WH; Cho JH; McDonald RP; Johnson GV
    J Biol Chem; 2005 Jan; 280(1):270-6. PubMed ID: 15522877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2.
    Wisessaowapak C; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol Pharmacol; 2021 May; 84():103626. PubMed ID: 33621689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Diaz-Nido J
    FEBS Lett; 1997 Jul; 411(2-3):183-8. PubMed ID: 9271202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
    Baum L; Hansen L; Masliah E; Saitoh T
    Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
    Woods YL; Cohen P; Becker W; Jakes R; Goedert M; Wang X; Proud CG
    Biochem J; 2001 May; 355(Pt 3):609-15. PubMed ID: 11311121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.